A Multi-Center, Open-Labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Lubiprostone (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Sucampo Pharmaceuticals
- 10 Oct 2013 Results have been presented at the 2013 North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting according to a Sucampo Pharmaceuticals media release. Results were also summarised in the media release.
- 09 Oct 2013 Results were published in the Journal of Pediatric Gastroenterology & Nutrition.
- 09 Oct 2013 Primary endpoint 'Spontaneous-bowel-movement' has been met.